🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the efficacy of XueZhiKang to i...
Status
Completed
Location
Robert Karns, MD A Medical Corporation
Start Date
2011-04
Trial ID
NCT01327014
Treatments Being Tested
This study compares the impact of Xuezhikang and atorvastatin on glucose me...
Status
Recruiting
Location
Beiqijia Community Health Service Center, Changping District, Beijing
Start Date
2024-12-31
Trial ID
NCT06750783
Treatments Being Tested
The objective of this study is to compare laboratory tests profiles of a bo...
Status
Completed
Location
NRC Research Institute
Start Date
2015-11
Trial ID
NCT02603770
Treatments Being Tested
Dyslipidemia contributes greatly to the formation and progression of athero...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT02057302
Treatments Being Tested
Both XueZhiKang and Statins are cholesterol-lowering medications that are o...
Status
Completed
Location
Second Hispital of Wenzhou Medical University
Start Date
2012-08
Trial ID
NCT01686451
Treatments Being Tested
This study is a prospective, randomized, open-label, multi-center trial. Th...
Status
Completed
Location
Peking University People's Hospital
Start Date
2022-08-02
Trial ID
NCT05238012
Treatments Being Tested
Double-dose statin regimen achieves merely 6% of decrease in low-density li...
Status
Recruiting
Location
The Second Hispital of Wenzhou Medical University
Start Date
2015-11
Trial ID
NCT02726555
Treatments Being Tested
The purpose of EMINENT study is to evaluate the efficacy of Xuezhikang or a...
Status
Unknown
Location
Fuwai Hospital
Start Date
2013-10
Trial ID
NCT02254824
Treatments Being Tested
This study is a prospective, randomized, open-label, and single center tria...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05976893
Treatments Being Tested